Science ministry opens bio forum with AI drug, BCI mission plans
South Korea's science ministry convened the 12th Bio Future Forum in Seoul, where officials outlined AI-driven drug development and brain-computer interface missions under a sovereign bio strategy.

The science ministry said it held the 12th Bio Future Forum at the Westin Josun Seoul hotel, where government officials and researchers set out plans to expand strategic investment in AI drug development, brain-computer interfaces, gene and cell therapies and synthetic biology.
The forum, hosted by the Ministry of Science and ICT and organized by the Korea Research Institute of Bioscience and Biotechnology's national bio policy center, has been used to identify major policy agendas in the bio sector. This year's theme was "Sovereign Bio: Opening the Future of AI-Bio Innovation with K-Moonshot," with sessions on the innovations and spillover effects of wider AI use and on securing independent advanced-technology capabilities amid global technology hegemony competition.
The ministry presented its strategy for the seven SEED advanced bio areas and the direction of the next basic plan for fostering biotechnology, while the Ministry of Food and Drug Safety introduced measures to support innovative biohealth products. Nam Jin-woo, the AI drug project director overseeing the K-Moonshot advanced bio mission, and Cho Il-joo, the BCI project director, announced implementation plans for their respective missions. Researchers also presented on bio big data in the AI era, on moving beyond automation to autonomous bio manufacturing, and on the institutions and ecosystem strategy for turning innovation into a strategic asset.
In a keynote address titled "The AI Great Transition and Sovereign Bio," Kim Tae-hyung, chief executive of BioNexus and a member of the National Bio Innovation Committee, stressed the importance of bio data, AI-bio models, computing and experimental infrastructure. The ministry also awarded 13 vice-premier commendations to individuals who contributed to bio research and development, industry growth and policy work this year.
"The role of AI in the research and development process is expanding, and the convergence of existing technologies with AI is being promoted and accelerated," Oh Dae-hyun, the ministry's future strategic technology policy director, said. "We must pool the capabilities of the private and public sectors so that the advanced bio field can become our country's future growth engine in this AI transition period."
"Through national projects such as the seven SEED and K-Moonshot, the government will expand strategic investment in future bio technologies including AI drug development, BCI, gene and cell therapies and synthetic biology, and do its utmost to realize a great leap forward in bio," he said.
What this article is based on
Every fact in this article can be checked against the primary documents below.
- Government과학기술정보통신부 과학기술 보도자료· Ministry of Science and ICT· accessed Nov. 12, 2026
- Government발표 주체·성격· korea.kr· accessed Nov. 12, 2026
© New Era Korea Daily. All rights reserved.